GO:2000210 positive regulation of anoikis: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000210 (positive regulation of anoikis) describes any process that activates or increases the frequency, rate or extent of anoikis, the detachment-induced form of programmed cell death.
• Anoikis is triggered when cells lose integrin-mediated attachment to the extracellular matrix, and positive regulators of anoikis lower the threshold for this death program.
• Key positive regulators include Cdc42 and Rac1, which modulate detachment-induced apoptosis in epithelial cells.
• Anoikis resistance is a hallmark of cancer metastasis and is promoted by factors such as NOX4/EGFR signaling, circ_0007534/DDX3X/DDX42 feedback, INHBB/TGF-beta signaling, and TGF-betaI/FERMT2/COL6A1 crosstalk [1,3,5,7].
• Anoikis-related genes are also emerging as biomarkers in non-cancer conditions such as heart failure and psoriasis [6,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate positive regulators of anoikis in disease-relevant cell systems.
Description
Anoikis is a specialized form of programmed cell death that occurs when cells detach from the extracellular matrix (ECM) or lose appropriate integrin-mediated adhesion. The Gene Ontology term GO:2000210, positive regulation of anoikis, captures any biological process that activates or increases the frequency, rate or extent of anoikis. This term is distinct from the core anoikis process itself and from negative regulation of anoikis (anoikis resistance), and it is essential for annotating signaling events that sensitize detached cells to death. Understanding positive regulation of anoikis is central to cancer biology because escape from anoikis is a prerequisite for metastasis, and restoring or enhancing anoikis sensitivity is a therapeutic goal [1,3,5,7]. Beyond oncology, anoikis-related gene signatures have been identified in heart failure and psoriasis, indicating broader physiological and pathological relevance [6,8]. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanisms, key genes, disease links, and experimental methods used to study positive regulation of anoikis.
positive regulation of anoikis At A Glance
| GO ID | GO:2000210 |
|---|---|
| GO term | positive regulation of anoikis |
| Ontology | biological_process |
| Synonym | positive regulation of detachment induced cell death; positive regulation of suspension induced apoptosis |
| Major function | Activates or increases the frequency, rate or extent of anoikis, the detachment-induced programmed cell death |
| Related process | Anoikis (GO:0006915-related), negative regulation of anoikis (anoikis resistance) |
| Cellular context | Integrin-mediated adhesion loss, ECM detachment, cytoskeletal signaling |
| Disease relevance | Cancer metastasis, heart failure, psoriasis, cholangiocarcinoma, colorectal cancer, gastric cancer |
What Is GO:2000210?
According to QuickGO, GO:2000210 (positive regulation of anoikis) is defined as any process that activates or increases the frequency, rate or extent of anoikis. In practical terms, it encompasses molecular events and signaling pathways that promote detachment-induced cell death, including activation of pro-apoptotic kinases, modulation of integrin signaling, and changes in gene expression that lower the threshold for anoikis. Synonyms include positive regulation of detachment induced cell death and positive regulation of suspension induced apoptosis. This term is a biological_process and is the positive counterpart to negative regulation of anoikis, which underlies anchorage-independent survival.
Why Is positive regulation of anoikis Important in Cell Biology?
Positive regulation of anoikis is critically important because it determines whether detached cells die or survive to colonize distant sites. In cancer, suppression of anoikis (negative regulation) enables metastasis, whereas enhancing positive regulation could restrict dissemination [1,3,5,7]. In non-malignant contexts, dysregulated anoikis contributes to heart failure and psoriasis, where anoikis-related genes have diagnostic and mechanistic value [6,8]. Thus, identifying and characterizing positive regulators of anoikis provides both mechanistic insight into cell death control and candidate targets for therapeutic intervention.
• Anoikis is a barrier to metastasis; positive regulation of anoikis prevents detached cancer cells from surviving.
• Cdc42 and Rac1 are established modulators of anoikis, linking Rho GTPase signaling to detachment-induced death.
• NOX4 and EGFR signaling can regulate anoikis resistance, highlighting redox and growth factor pathways as targets.
• Circ_0007534 promotes cholangiocarcinoma stemness and anoikis resistance via DDX3X/DDX42 feedback, illustrating RNA-level control.
• INHBB promotes colorectal cancer liver metastasis by regulating TGF-beta/Smad, EMT, and anoikis resistance.
• TGF-betaI/FERMT2/COL6A1 crosstalk drives peritoneal metastasis in gastric cancer, linking ECM remodeling to anoikis.
• Anoikis-related genes are biomarkers in heart failure, expanding relevance beyond cancer.
• STAT3 and BIRC5 have been identified as anoikis-related biomarkers in psoriasis.
• Positive regulation of anoikis is a potential therapeutic axis: enhancing it may suppress metastatic seeding [1,5].
• CRISPR-based models allow causal testing of candidate positive regulators in disease-relevant cells.
What Happens During positive regulation of anoikis?
Detection of adhesion loss
In simple terms: When a cell loses its grip on the matrix, it senses that something is wrong.
Anoikis is initiated when integrin-mediated attachment to the ECM is lost or inappropriate, leading to changes in integrin signaling and cytoskeletal organization. Positive regulation of anoikis begins with the cell's ability to detect this detachment and convert it into a death signal. Integrins serve as the primary adhesion receptors, and their disengagement triggers downstream events that can promote apoptosis.
Rho GTPase and cytoskeletal signaling
In simple terms: Small signaling switches inside the cell help decide whether detachment leads to death.
Cdc42 and Rac1 are Rho family GTPases that regulate anoikis; experimental evidence shows that they modulate detachment-induced cell death in epithelial cells. Their activity influences cytoskeletal dynamics and survival signaling, thereby affecting the frequency and extent of anoikis. Positive regulation of anoikis can therefore involve activation of specific GTPase-dependent pathways that sensitize cells to detachment.
Redox and growth factor signaling
In simple terms: Oxidative stress and growth factor signals can tip the balance toward cell death after detachment.
NADPH oxidase 4 (NOX4) and epidermal growth factor receptor (EGFR) have been implicated in the regulation of anoikis resistance, indicating that redox balance and growth factor signaling are key nodes. Positive regulation of anoikis may occur when these pro-survival signals are reduced or when pro-oxidant events predominate, leading to increased detachment-induced apoptosis.
Transcriptional and post-transcriptional control
In simple terms: Genes and RNA molecules can be switched on or off to make cells more sensitive to detachment.
Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of the parental gene DDX42, demonstrating that circular RNAs and RNA-binding proteins can modulate anoikis sensitivity. Conversely, positive regulation of anoikis can involve suppression of such pro-survival circuits. INHBB promotes liver metastasis of colorectal cancer via TGF-beta/Smad signaling, EMT, and anoikis resistance, indicating that TGF-beta pathway components can act as negative regulators whose inhibition may enhance anoikis.
ECM crosstalk and tumor-stroma interactions
In simple terms: The environment around a cell can send signals that either block or promote detachment-induced death.
A TGF-betaI/FERMT2/COL6A1 reciprocal loop drives tumor-stroma crosstalk and promotes peritoneal metastasis in gastric cancer, linking ECM components to anoikis regulation. Positive regulation of anoikis may be achieved by disrupting such pro-survival ECM crosstalk, thereby restoring sensitivity to detachment-induced death.
Key Genes Involved in GO:2000210 positive regulation of anoikis
The following genes and proteins have been experimentally linked to the regulation of anoikis, including positive regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cdc42 | Rho GTPase modulating anoikis | Regulates detachment-induced cell death in epithelial cells |
| Rac1 | Rho GTPase modulating anoikis | Regulates detachment-induced cell death in epithelial cells |
| NOX4 | NADPH oxidase involved in anoikis resistance | Redox regulation of anoikis |
| EGFR | Growth factor receptor affecting anoikis resistance | Signaling node in anoikis regulation |
| DDX3X | RNA helicase mediating circ_0007534 effects | Promotes anoikis resistance in cholangiocarcinoma |
| DDX42 | Parental gene regulated by DDX3X feedback | Linked to cholangiocarcinoma stemness and anoikis resistance |
| INHBB | TGF-beta superfamily ligand | Promotes colorectal cancer liver metastasis and anoikis resistance |
| TGF-beta/Smad | Signaling pathway | Regulates EMT and anoikis resistance |
| FERMT2 | Focal adhesion protein | Part of TGF-betaI/FERMT2/COL6A1 loop in gastric cancer |
| COL6A1 | Extracellular matrix collagen | Tumor-stroma crosstalk and anoikis regulation |
| STAT3 | Transcription factor | Anoikis-related biomarker in psoriasis |
| BIRC5 | Survivin, apoptosis inhibitor | Anoikis-related biomarker in psoriasis |
| Integrins | ECM adhesion receptors | Central to anoikis initiation |
| Circ_0007534 | Circular RNA | Promotes anoikis resistance in cholangiocarcinoma |
How Is positive regulation of anoikis Regulated?
Positive regulation of anoikis is controlled by a balance between pro-survival and pro-death signals. Rho GTPases such as Cdc42 and Rac1 modulate the sensitivity of detached cells to apoptosis. Redox signaling via NOX4 and growth factor signaling via EGFR influence anoikis resistance, and their inhibition can shift the balance toward anoikis. TGF-beta/Smad signaling, EMT programs, and ECM crosstalk involving INHBB, FERMT2, and COL6A1 can suppress anoikis, so their disruption may enhance positive regulation [5,7]. At the RNA level, circ_0007534 and DDX3X/DDX42 feedback loops regulate anoikis resistance in cholangiocarcinoma. These pathways collectively determine whether a detached cell survives or undergoes anoikis.
positive regulation of anoikis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DDX3X / DDX42 / circ_0007534 | Cholangiocarcinoma stemness and anoikis resistance | Knockout or knockdown in cholangiocarcinoma cell lines |
| INHBB | Colorectal cancer liver metastasis | Knockout or overexpression in colorectal cancer cells |
| FERMT2 / COL6A1 | Gastric cancer peritoneal metastasis | Knockout in gastric cancer cells and stromal co-cultures |
| NOX4 / EGFR | Anoikis resistance in cancer | Point mutation or knockout in cancer cell lines |
| STAT3 / BIRC5 | Psoriasis | Knockout or overexpression in keratinocyte models |
Cancer metastasis and anoikis resistance
Anoikis resistance is a critical step in metastasis, allowing detached cancer cells to survive and colonize distant organs [1,3,5,7]. In cholangiocarcinoma, circ_0007534 promotes stemness and resistance to anoikis through DDX3X-mediated feedback on DDX42. In colorectal cancer, INHBB promotes liver metastasis via TGF-beta/Smad signaling, EMT, and anoikis resistance. In gastric cancer, a TGF-betaI/FERMT2/COL6A1 loop drives peritoneal metastasis. NOX4 and EGFR signaling also regulate anoikis resistance, highlighting redox and growth factor pathways as therapeutic targets. Positive regulation of anoikis would counteract these mechanisms.
Heart failure
Anoikis-related genes have been identified in heart failure through bioinformatics and experimental validation, suggesting that detachment-induced death pathways contribute to cardiac pathology. Modulating positive regulation of anoikis may therefore have therapeutic implications in heart failure, although the precise mechanisms require further study.
Psoriasis
STAT3 and BIRC5 have been identified as anoikis-related biomarkers in psoriasis, linking detachment-induced cell death pathways to inflammatory skin disease. This suggests that positive regulation of anoikis may be relevant to keratinocyte homeostasis and psoriasis pathogenesis.
From positive regulation of anoikis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene a positive regulator of anoikis? | CRISPR knockout in adherent and suspension culture [2,4] |
| Does a specific mutation alter anoikis sensitivity? | Point-mutation knock-in of candidate gene |
| Does a disease-associated variant affect anoikis? | Knock-in of variant allele in cell lines [1,5] |
| Where does a protein localize during anoikis? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a gene enhance anoikis? | Overexpression cell model in detachment assays [1,5] |
| Which pathways mediate anoikis resistance? | CRISPR library screening and bioinformatics [6,8] |
How to Study the positive regulation of anoikis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Suspension culture / poly-HEMA | Detachment-induced cell death | Anoikis assays |
| CRISPR knockout | Loss-of-function effect on anoikis | Causal testing of candidate genes [1,5] |
| Point-mutation knock-in | Effect of specific mutations | Dissecting signaling domains |
| RNA-seq | Transcriptional changes | Identifying anoikis-related signatures [6,8] |
| Bioinformatics | Gene network and pathway enrichment | Biomarker discovery [6,8] |
| Proteomics | Protein expression and modifications | Mapping signaling pathways [5,7] |
| Immunofluorescence | Protein localization and cytoskeleton | Studying detachment responses |
| CRISPR library screening | Genome-wide regulators of anoikis | High-throughput discovery [6,8] |
Detachment and anoikis assays
Anoikis is commonly studied by culturing cells in suspension or on poly-HEMA-coated plates to prevent adhesion, followed by viability and apoptosis assays. These methods directly measure the frequency and extent of detachment-induced cell death and are used to test positive regulators [2,3].
CRISPR knockout and point-mutation models
CRISPR-Cas9 knockout of candidate genes allows causal testing of their role in positive regulation of anoikis [1,5]. Point-mutation knock-in can dissect specific residues or domains required for anoikis regulation, as demonstrated for signaling proteins like NOX4 and EGFR.
Transcriptomics and bioinformatics
RNA sequencing and bioinformatics analyses have identified anoikis-related gene signatures in heart failure and psoriasis, and circular RNA/mRNA networks in cholangiocarcinoma [1,6,8]. These approaches nominate candidate positive regulators for functional validation.
Proteomics and signaling analysis
Proteomic and phosphoproteomic analyses can reveal changes in TGF-beta/Smad, EMT, and focal adhesion signaling during anoikis regulation [5,7]. Such methods help map the molecular events downstream of candidate regulators.
How CRISPR Can Be Used to Study GO:2000210 positive regulation of anoikis
Knockout
CRISPR knockout of candidate genes is used to determine whether they are required for positive regulation of anoikis. For example, knocking out DDX3X or DDX42 would test their role in cholangiocarcinoma anoikis resistance. Similarly, knockout of INHBB or FERMT2 can assess their contribution to anoikis suppression in colorectal and gastric cancers [5,7].
Point Mutation
Point-mutation knock-in allows precise testing of residues or domains implicated in anoikis regulation. This is particularly useful for signaling proteins such as NOX4 and EGFR, where specific mutations may alter redox or kinase activity and thereby affect anoikis sensitivity.
Knock-in
Knock-in of tagged or variant alleles enables tracking of protein localization and function during anoikis. For example, tagging integrins or Rho GTPases can reveal their dynamics upon detachment [2,4]. Disease-associated variants in anoikis-related genes can also be knocked in to study their impact [1,5].
Overexpression
Overexpression models are used to test whether a gene enhances anoikis. Overexpressing a positive regulator such as a pro-apoptotic factor or a GTPase may increase detachment-induced death, while overexpressing INHBB or circ_0007534 may promote resistance [1,5]. These models complement loss-of-function studies.
How EDITGENE Supports positive regulation of anoikis Research
Researchers studying positive regulation of anoikis-related genes often need to determine whether a candidate gene is causally involved in detachment-induced cell death or resistance. EDITGENE provides comprehensive CRISPR-based services to enable such functional studies in disease-relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of anoikis research.
Frequently Asked Questions About positive regulation of anoikis
What is GO:2000210 positive regulation of anoikis?
GO:2000210 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of anoikis, the detachment-induced form of programmed cell death.
What genes are involved in positive regulation of anoikis?
Genes implicated in anoikis regulation include Cdc42, Rac1, NOX4, EGFR, DDX3X, DDX42, INHBB, FERMT2, COL6A1, STAT3, and BIRC5, among others [1,2,3,5,7,8].
How is anoikis different from apoptosis?
Anoikis is a specific form of apoptosis triggered by loss of integrin-mediated attachment to the extracellular matrix, whereas apoptosis can be induced by many stimuli.
What is anoikis resistance?
Anoikis resistance is the ability of cells to survive without attachment, a hallmark of metastatic cancer cells and the opposite of positive regulation of anoikis [1,3,5,7].
Which signaling pathways regulate anoikis?
Rho GTPase signaling, redox signaling via NOX4, EGFR signaling, TGF-beta/Smad signaling, and ECM crosstalk involving FERMT2 and COL6A1 are key pathways [2,3,5,7].
How do you study positive regulation of anoikis experimentally?
Common methods include suspension culture assays, CRISPR knockout or knock-in, RNA-seq, proteomics, and bioinformatics analyses [1,3,4,6,8].
Is anoikis relevant to heart failure?
Yes, anoikis-related genes have been identified in heart failure through bioinformatics and experimental validation.
What is the role of STAT3 and BIRC5 in anoikis?
STAT3 and BIRC5 have been identified as anoikis-related biomarkers in psoriasis, suggesting a role in inflammatory skin disease.
Can CRISPR be used to study anoikis?
Yes, CRISPR knockout, point-mutation knock-in, knock-in, and overexpression models are widely used to test the causal role of genes in anoikis regulation [1,3,5,7].
What is the clinical significance of positive regulation of anoikis?
Enhancing positive regulation of anoikis could suppress metastasis by preventing detached cancer cells from surviving, making it a potential therapeutic strategy [1,5,7].
Conclusion
GO:2000210 positive regulation of anoikis is a critical biological process that governs whether detached cells die or survive. Its dysregulation contributes to cancer metastasis, heart failure, and psoriasis, and key regulators include Rho GTPases, NOX4/EGFR, TGF-beta/Smad components, and RNA-binding proteins [1,2,3,5,6,7,8]. Continued research using CRISPR-based models and multi-omics approaches will clarify how positive regulation of anoikis can be harnessed therapeutically.
References
- 1. Liu S et al.. 2024. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42.. Cell Signal 118:111141 PMID: 38492624
- 2. Cheng TL et al.. 2004. Regulation of anoikis by Cdc42 and Rac1.. Exp Cell Res 295(2):497-511 PMID: 15093747
- 3. Kim H et al.. 2017. Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor.. Br J Cancer 116(3):370-381 PMID: 28081539
- 4. Frisch SM et al.. 1997. Integrins and anoikis.. Curr Opin Cell Biol 9(5):701-6 PMID: 9330874
- 5. Yang N et al.. 2026. INHBB promotes liver metastasis of colorectal cancer via regulation of TGF-β/Smad signaling, EMT and anoikis resistance.. Tissue Cell 99:103258 PMID: 41380489
- 6. Zhang L et al.. 2025. Identification of anoikis-related genes in heart failure: bioinformatics and experimental validation.. Hereditas 162(1):163 PMID: 40819162
- 7. He C et al.. 2025. TGF-βI/FERMT2/COL6A1 Reciprocal Loop Drives Tumor-Stroma Crosstalk and Promotes Peritoneal Metastasis in Gastric Cancer.. Int J Biol Sci 21(13):5859-5873 PMID: 41079932
- 8. Bai W et al.. 2025. Identification of STAT3 and BIRC5 as anoikis-related biomarkers in psoriasis.. Sci Rep 15(1):28929 PMID: 40775257
